CAMP4 Therapeutics Corporation Common Stock (NASDAQ: CAMP) last traded at $4.48, up 0.45% on the session. The quote above updates while this page is open; the figures below are drawn from CAMP4 Therapeutics Corporation Common Stock’s own filings and are restated only when a new one is published.
CAMP4 Therapeutics Corporation Common Stock trades on NASDAQ under the ticker CAMP. Its market capitalisation is $281.13 million.
Valuation measures for CAMP4 Therapeutics Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $281.13M |
|---|---|
| Enterprise value | $288.86M |
| Price / sales | 66.68 |
| Beta | 1.69 |
Trailing-twelve-month figures tagged in CAMP4 Therapeutics Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $4.22M |
|---|---|
| Net income (TTM) | -$107.24M |
| Operating margin | -1254.22% |
| Cash | $86.40M |
Range and volume for CAMP over the past 52 weeks.
| 52-week high | $7.75 |
|---|---|
| 52-week low | $1.41 |
| Volume | 124.9K |
| Average volume | 233.3K |
| Previous close | $4.46 |
Dividend history for CAMP4 Therapeutics Corporation Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.